Table 4.
Variables | HIV Status | Crude OR (95% CI) | Adjusted OR (95% CI) | |
---|---|---|---|---|
Positive n (%) | Negative n (%) | |||
Age at enrollment (n=472) ≤6 weeks >6 weeks |
7 (5.0) 35 (10.5) |
132 (95,0) 298 (89.5) |
1.0 2.21 (0.95–5.11) |
1.0 1.27 (0.51–3.18) |
Gender (n=472) Male Female |
16 (7.5) 26 (10.1) |
198 (92.5) 232 (89.9) |
1.0 1.38 (0.72–2.65) |
1.0 1.64 (0.79–3.40) |
Residence (n=472) Rural Urban |
29 (8.8) 13 (9.1) |
300 (91.2) 130 (90.9) |
1.0 1.03 (0.52–2.05) |
1.0 1.08 (0.50–2.30 |
Type of delivery (n=461)a Cesarean Vaginal |
12 (7.2) 28 (9.4) |
154 (92.8) 270 (90.6) |
1.0 1.33 (0.65–2.69) |
1.0 0.96 (0.44–2.08) |
Maternal ARV intervention (n=469) Yesb No |
1 (0.4) 41 (17.1) |
228 (99.6) 199 (82.9) |
1.0 46.5 (6.4–344) |
1.0 40.6 (5.5–308) |
Infant ARV intervention (n=472) NVP 6 weeks sdNVP+AZT 4 weeks sdNVP+AZT 1 week No |
6 (3.8) 12 (7.5) 8 (8.2) 16 (27.6) |
151 (96.2) 148 (92.5) 89 (91.8) 42 (72.4) |
1.0 2.2 (0.7–6.7) 2.0 (0.7–5.5) 9.5 (3.5–26.0) |
1.0
|
Notes: aType of delivery was recorded in 461 (5 twins, 6 missing data): bWomen were on ART before and during pregnancy, excluding NVP prophylaxis at delivery.
Abbreviations: ARV, antiretrovirals; OR, odds ratio.